Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Benzodiazepine

or [[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]]

& fda max: 10 mg/d

Use the filters below to narrow your results.

Alprazolam (1) · Dapagliflozin (1)

Farxiga (US), Forxiga (international) (1) · Xanax (1)

None (1) · GABA-A positive allosteric modulator'"`UNIQ--ref-00000067-QINU`"' '"`UNIQ--vote-00000068-QINU`"' (1)

'"`UNIQ--vote-00000069-QINU`"', '"`UNIQ--vote-0000006A-QINU`"', '"`UNIQ--vote-0000006B-QINU`"' (1) · '"`UNIQ--vote-0000054E-QINU`"', '"`UNIQ--vote-0000054F-QINU`"', '"`UNIQ--vote-00000550-QINU`"', '"`UNIQ--vote-00000551-QINU`"' (1)

0.25 mg (1) · 10 mg PO once daily in the morning; 5 mg starting in heart failure (1)

0.25 mg, 0.5 mg, 1 mg, 2 mg tablets (immediate-release and orally disintegrating); 0.5 mg, 1 mg, 2 mg, 3 mg extended-release tablets; 1 mg/mL oral concentrate (1) · 5 mg, 10 mg tablets (1)

Oral (2)

30-60 min (immediate-release); 1-2 h (extended-release) (1) · Glycosuria within hours; HbA1c effect at 12 weeks; CV/renal benefits over months (1)

24 hours (1) · 6 h (immediate-release); ~11 h (extended-release) (1)

11-13 h (immediate-release); 11-16 h (extended-release) (1) · ~12.9 hours'"`UNIQ--ref-00000552-QINU`"' (1)

80-90% oral (1) · ~78% (oral; high-fat meal modestly reduces but is not clinically significant)'"`UNIQ--ref-00000553-QINU`"' (1)

Avoid in second and third trimesters; fetal SGLT2 inhibition disrupts kidney development.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) · Category D'"`UNIQ--ref-0000006C-QINU`"' (1)

Schedule IV (US) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 2 results in range #1 to #2.

A

Alprazolam

D

Dapagliflozin

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"